RNA interference based silencing (RNAi) of CYLD also results in activation of JNK signalling and Cyld deficient mice develop severe colonic inflammation, colitis-associated tumours, and hepatocellular carcinoma [13–15]. This evidence concerns the gene CYLD and colitis.